The Role of Vitamin D3 and Calcium Supplementation in Attenuating T2DM Severity
NCT ID: NCT02464462
Last Updated: 2015-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
11 participants
INTERVENTIONAL
2010-05-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes
NCT00436475
Effects of Vitamin D and Calcium Supplementation on Inflammatory Biomarkers and Adypocytokines in Diabetic Patients
NCT01662193
Effect of Vitamin D Supplementation on Glucose Tolerance in Subjects at Risk for Diabetes With Low Vitamin D.
NCT01726777
Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
NCT04183257
Can Vitamin D Supplementation Prevent Type 2 Diabetes?
NCT02112721
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CaD Group
This arm received total of 1800 IU of vitamin D3 and 720 mg of calcium
vitamin D3 and calcium
1800 IU vitamin D3 plus 720 mg Calcium
Placebo Group
This arm received rice powder pills
Placebo
Rice powder pills
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vitamin D3 and calcium
1800 IU vitamin D3 plus 720 mg Calcium
Placebo
Rice powder pills
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-white, post menopausal female
* Have access to Community Health Center
Exclusion Criteria
* kideny disease
* gluten allergy
40 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Women's Health in Women's Hands Community Health Center
UNKNOWN
York University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MAZEN J HAMADEH
Associate Progessor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU 2013-024
Identifier Type: OTHER
Identifier Source: secondary_id
220
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.